Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J, Banus HA, Gremmer ER, Ferguson H, de la Fonteyne-Blankestijn LJ, Vermeulen JP, Dormans JA, Tommassen J, van der Ley P, Mooi FR, Vandebriel RJ.
Geurtsen J, et al. Among authors: de la fonteyne blankestijn lj.
Clin Vaccine Immunol. 2007 Jul;14(7):821-9. doi: 10.1128/CVI.00074-07. Epub 2007 May 9.
Clin Vaccine Immunol. 2007.
PMID: 17494641
Free PMC article.